comparemela.com
Home
Live Updates
FDA Requests Warnings on CAR-T Cell Therapies, Citing Secondary Cancers : comparemela.com
FDA Requests Warnings on CAR-T Cell Therapies, Citing Secondary Cancers
The Food and Drug Administration is requesting that CAR-T cell therapies now come with a Boxed Warning about secondary malignancies that have been reported in patients who undergo these treatments.
Related Keywords
David Mitchell ,
Brucel Levine ,
Reuters ,
University Of Pennsylvania ,
Drug Administration ,
Twitter ,
National Institutes Of Health ,
Bristol Myers Squibb ,
Novartis ,
Perelman School Of Medicine ,
Boxed Warnings ,
National Institutes ,
Safety Labeling Change Notification ,
Patients Respond ,
Expert Weighs ,
Edward Netter Professor ,
Cancer Gene Therapy ,
Perelman School ,
Event Reporting System ,
Nature Medicine ,
Affordable Drugs ,
News ,
Myeloma ,
Leukemia ,
Lymphoma ,
Hodgkin Lymphoma ,
Blood Cancer ,
Fda ,
Cart Cell Therapies ,
comparemela.com © 2020. All Rights Reserved.